• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.01% Nasdaq Up0.26%

    GenVec, Inc. (GNVC)

    1.71 Down 0.01(0.58%) Nov 25, 3:59PM EST
    ProfileGet Profile for:
    GenVec, Inc.
    910 Clopper Road
    Suite 220N
    Gaithersburg, MD 20878
    United States - Map
    Phone: 240-632-0740
    Fax: 240-632-0735
    Website: http://www.genvec.com

    Index Membership:N/A
    Full Time Employees:11

    Business Summary 

    GenVec, Inc., a clinical-stage biopharmaceutical company, focuses on using its adenovector gene delivery platform to develop a pipeline of therapeutics and vaccines in the United States. Its vaccine against foot and mouth disease in cattle has been approved. The company’s lead product candidate, CGF166 is in Phase 1/2 clinical study for the treatment of hearing loss and balance disorders. Its product pipeline also includes GV2311, a vaccine for respiratory syncytial virus; and GV2207, a herpes simplex virus-2 immunotherapeutic. The company is also developing vaccines against other infectious diseases, such as Enterovirus D68 (EV-D68) and malaria. GenVec, Inc. has partnership agreements with Novartis AG, Laboratory of Malaria Immunology and Vaccinology, Washington University, and Merial Limited, as well as with TheraBiologics, Inc. to develop cancer therapeutics. The company was founded in 1992 and is based in Gaithersburg, Maryland.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on GenVec, Inc.

    Key Executives 
    Mr. Douglas J. Swirsky CPA, CFA, 46
    Chief Exec. Officer, Pres, Corp. Sec. and Director
    Dr. Douglas E. Brough Ph.D., 60
    Chief Scientific Officer
    Dr. Bryan T. Butman Ph.D., 62
    Sr. VP of Devel.
    Dr. Zola P. Horovitz Ph.D., 80
    Mr. James Vincent Lambert , 51
    Sr. Director of Accounting & Fin., Treasurer and Corp. Controller
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders